-
Mitochondrial Metabolism Shows Promise as Target for Cancer Therapy
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
-
Continuous Glucose Monitoring May Help Reduce Hypoglycemia
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
-
Medical Student Helps Organize Outreach for Older Adults Experiencing COVID-19 Isolation
Emma Office, a rising second year medical student and co-leader of the student COVID-19 volunteer effort at Feinberg, helped organize a successful phone call outreach program for older adults at risk of experiencing social isolation during the pandemic.
-
Drug Shortens Flu Recovery in Vulnerable Patients
Patients with influenza at risk of complications recovered more quickly after early treatment with the drug baloxavir marboxil, according to a study published in The Lancet Infectious Diseases.
-
New Inhibitor Starves HIV
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
-
Protein Unexpectedly Impacts Intracellular Transport in Neurons
Northwestern Medicine investigators have discovered that a specific protein known for its role in cell division also impacts the direction of intracellular transport in neurons.
-
New Therapy Extends Breast Cancer Survival Rate, Prevents Reoccurrence
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.
-
Alumni Connect with Students for ‘Heart-to-Hearts’
Virtual Heart-to-Hearts connects medical students with Feinberg alumni for conversations about medical specialties, residency applications and more.
-
COVID-19 Complicates Cancer Treatment
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
-
Novel Drug Improves Survival in Advanced Prostate Cancer
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
-
Support Tool Aims to Streamline Decision Process for Cesarean Delivery
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
-
Critical Function of Cilia Protein Discovered
A protein gives motile cilia part of their structure, according to a recent Northwestern Medicine study.
-
Chemotherapy Drug Mitigates Allergic Response
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
-
Chimeric Toxin Slows Cancer Growth
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
-
New Role for RNA Splicing in Insulin Regulation
The gene transcription machinery that controls circadian rhythms also regulates insulin release in the pancreas, according to a Northwestern Medicine study.
-
Exploring Protein Vital for Bone Marrow Transplants
A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.
-
New Assistant Deans Named in Medical Education
In recognition of their track record of excellence and achievement, three Feinberg faculty members have been promoted to the position of assistant dean of medical education.
-
Strategies for Evaluating Breast Cancer with Machine Learning
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
-
Remembering James Houk, PhD
James Houk, PhD, former chair and professor of Physiology whose Feinberg career spanned more than 40 years, passed away on June 11.
-
New Genetic Regulators Could Improve Cancer Immunotherapy
A genetic screen has revealed previously unknown regulators of Foxp3, a transcription factor that, when deactivated, may improve patient response to aggressive cancers.
